Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1987;75:1170-1177

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francis, C. W.
Right arrow Articles by Marder, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francis, C. W.
Right arrow Articles by Marder, V. J.

Circulation, Vol 75, 1170-1177, Copyright © 1987 by American Heart Association


ARTICLES

Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction

CW Francis, DG Connaghan, WL Scott and VJ Marder

Thrombin cleaves fibrinopeptides from fibrinogen, converting it to fibrin monomer, and activates factor XIII, which catalyzes the formation of intermolecular epsilon-(gamma-glutamyl)-lysine bonds to stabilize the fibrin polymer. The formation of factor XIIIa-catalyzed fibrin polymers during clotting of plasma and purified fibrinogen in vivo was followed by a sodium dodecyl sulfate agarose gel technique, and an increase in both amount and size of gamma-chain cross-linked polymers was demonstrated before visible clot formation. Plasma from patients presenting with acute myocardial infarction showed increases in the plasma concentration of fibrin polymer and in the proportion of total fibrinogen present as polymer, as determined by a quantitative adaptation of the electrophoretic technique. The plasma concentration in patients with subendocardial or transmural myocardial infarction showed significant (p less than .005) increases to 4.0 +/- 1.0% and 3.6 +/- .8%, respectively, as compared with the concentration in normal plasma (0.8 +/- 0.1%). There was no difference in plasma concentration in samples from patients with transmural compared with those with subendocardial myocardial infarction. This study provides the first demonstration of factor XIIIa cross-linked fibrin polymers in thrombotic disease and indicates the presence of increased activity of both thrombin and factor XIIIa in patients with acute myocardial infarction.


This article has been cited by other articles:


Home page
ChestHome page
H. Kubo, K. Nakayama, M. Yanai, T. Suzuki, M. Yamaya, M. Watanabe, and H. Sasaki
Anticoagulant Therapy for Idiopathic Pulmonary Fibrosis
Chest, September 1, 2005; 128(3): 1475 - 1482.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. J. Catto
Genetic aspects of the hemostatic system in cerebrovascular disease
Neurology, September 1, 2001; 57(90002): S24 - 30.
[Abstract] [Full Text]


Home page
Exp. Biol. Med.Home page
M. S. Williams and P. F. Bray
Genetics of Arterial Prothrombotic Risk States
Experimental Biology and Medicine, May 1, 2001; 226(5): 409 - 419.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
J. Figueras, Y. Monasterio, R. M. Lidon, E. Nieto, and J. Soler-Soler
Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2036 - 2043.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. J. Teede, B. P. McGrath, J. J. Smolich, E. Malan, D. Kotsopoulos, Y.-L. Liang, and R. E. Peverill
Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis
Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1404 - 1409.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. Blackwell, Z. Haroon, G. Broadwater, D. Berry, L. Harris, J. D. Iglehart, M. Dewhirst, and C. Greenberg
Plasma D-Dimer Levels in Operable Breast Cancer Patients Correlate With Clinical Stage and Axillary Lymph Node Status
J. Clin. Oncol., February 1, 2000; 18(3): 600 - 600.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M.-C. Tataru, J. Heinrich, R. Junker, H. Schulte, A. von Eckardstein, G. Assmann, and E. Koehler
D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction
Eur. Heart J., October 2, 1999; 20(20): 1493 - 1502.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. A. S. Ariens, H. P. Kohler, M. W. Mansfield, and P. J. Grant
Subunit Antigen and Activity Levels of Blood Coagulation Factor XIII in Healthy Individuals : Relation to Sex, Age, Smoking, and Hypertension
Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 2012 - 2016.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. V. Lee, G. A. Ewald, C. R. McKenzie, and P. R. Eisenberg
The Relationship of Soluble Fibrin and Cross-linked Fibrin Degradation Products to the Clinical Course of Myocardial Infarction
Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 628 - 633.
[Abstract] [Full Text]